Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
J Hum Hypertens ; 30(6): 379-85, 2016 06.
Article in English | MEDLINE | ID: mdl-26538381

ABSTRACT

Primary aldosteronism due to unilateral aldosterone-producing adenoma (APA) is a surgically curable form of hypertension. Bilateral APA can also be surgically curable in theory but few successful cases can be found in the literature. It has been reported that even using successful adrenal venous sampling (AVS) via bilateral adrenal central veins, it is extremely difficult to differentiate bilateral APA from bilateral idiopathic hyperaldosteronism (IHA) harbouring computed tomography (CT)-detectable bilateral adrenocortical nodules. We report a case of bilateral APA diagnosed by segmental AVS (S-AVS) and blood sampling via intra-adrenal first-degree tributary veins to localize the sites of intra-adrenal hormone production. A 36-year-old man with marked long-standing hypertension was referred to us with a clinical diagnosis of bilateral APA. He had typical clinical and laboratory profiles of marked hypertension, hypokalaemia, elevated plasma aldosterone concentration (PAC) of 45.1 ng dl(-1) and aldosterone renin activity ratio of 90.2 (ng dl(-1) per ng ml(-1 )h(-1)), which was still high after 50 mg-captopril loading. CT revealed bilateral adrenocortical tumours of 10 and 12 mm in diameter on the right and left sides, respectively. S-AVS confirmed excess aldosterone secretion from a tumour segment vein and suppressed secretion from a non-tumour segment vein bilaterally, leading to the diagnosis of bilateral APA. The patient underwent simultaneous bilateral sparing adrenalectomy. Histopathological analysis of the resected adrenals together with decreased blood pressure and PAC of 5.2 ng dl(-1) confirmed the removal of bilateral APA. S-AVS was reliable to differentiate bilateral APA from IHA by direct evaluation of intra-adrenal hormone production.


Subject(s)
Adrenal Cortex Neoplasms/diagnosis , Adrenal Cortex Neoplasms/surgery , Adrenalectomy/methods , Adrenocortical Adenoma/diagnosis , Adrenocortical Adenoma/surgery , Aldosterone/blood , Biomarkers, Tumor/blood , Blood Specimen Collection/methods , Organ Sparing Treatments , Adrenal Cortex Neoplasms/blood , Adrenal Cortex Neoplasms/metabolism , Adrenocortical Adenoma/blood , Adrenocortical Adenoma/metabolism , Adult , Aldosterone/metabolism , Biomarkers, Tumor/metabolism , Biopsy , Diagnosis, Differential , Humans , Immunohistochemistry , Male , Predictive Value of Tests , Tomography, X-Ray Computed , Treatment Outcome , Veins
2.
Neoplasma ; 59(2): 224-32, 2012.
Article in English | MEDLINE | ID: mdl-22248281

ABSTRACT

Gastrin-releasing peptide (GRP) belongs to the family of bombesin-like peptides. GRP was demonstrated to stimulate the proliferation and invasiveness of androgen-independent prostate carcinoma. GRP mediates its action through the membrane-bound receptor, GRP receptor (GRPR), which is characterized by a high-affinity binding for both GRP and bombesin. In human prostate cancer tissue, GRPR mRNA was reported to be detectable in more than 90% but its immunolocalizaition has not been reported. Therefore, in this study we immunolocalized GRPR in 51 human prostate cancer cases and correlated the findings with several clinicopathological parameters in order to better understand the function and regulation of GRPR in human prostate cancer. GRPR was immnolocalized in carcinoma cells and their values were significantly associated with Gleason score and immunoreactivity of estrogen receptor ßcx (ERßcx) that is one of splicing variants of ligand dependent transcription factor, ERß, and considered to be prognostic factor of prostate cancer patients. The amounts of GRPR and ERßcx mRNA in three prostate cancer cell lines PC-3, DU-145 and LNCaP evaluated by quantitative RT-PCR (qPCR) analysis were also significantly correlated. In addition, we established stable transformants of prostate carcinoma cell line PC-3 introduced with ERßcx, and confirmed that GRPR mRNA was induced in ERßcx over-expressing PC-3 cells by qPCR analysis. These results also suggest that ERßcx contributes to prostate cancer development possibly through mediating GRPR expression in carcinoma cells.


Subject(s)
Estrogen Receptor beta/genetics , Estrogen Receptor beta/metabolism , Prostatic Neoplasms/genetics , Prostatic Neoplasms/metabolism , Receptors, Bombesin/genetics , Receptors, Bombesin/metabolism , Adenocarcinoma/genetics , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Aged , Blotting, Western , Gene Expression Regulation, Neoplastic , Humans , Immunoenzyme Techniques , Luciferases/metabolism , Male , Middle Aged , Neoplasm Grading , Prognosis , Prostatic Neoplasms/pathology , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Tumor Cells, Cultured
3.
J Hum Hypertens ; 25(2): 114-21, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20463748

ABSTRACT

The patient was a 54-year-old woman who developed a right adrenal tumour, Cushingoid features, elevated levels of cortisol that were not suppressed by 1 nor 8 mg of dexamethasone, and suppression of adrenocorticotropin (ACTH) during treatment for severe hypertension. Computed tomography (CT) revealed a right adrenal tumour and an atrophic left adrenal gland. In addition, elevated plasma aldosterone concentration (PAC) and suppressed plasma renin activity (PRA) with an aldosterone-to-renin ratio of 128 (ng per 100 ml per ng ml⁻¹ h⁻¹) suggested aldosterone excess. Urinary excretion of aldosterone was relatively high, and the captopril and rapid ACTH tests resulted in no response of PRA and exaggerated increase in PAC, respectively. ACTH-loaded adrenal venous sampling showed bilateral excess of aldosterone with right predominance of cortisol. Right laparoscopic partial adrenalectomy (ADX) and immunohistochemical analysis showed both a cortisol-producing adenoma and an aldosterone-producing microadenoma (microAPA) within the attached adrenal, which had not been detected by CT preoperatively. After the right partial ADX, her blood pressure, aldosterone level and suppressed PRA remained unchanged. Subsequently, laparoscopic total left ADX was performed. Two microAPAs with paradoxical hyperplasia were revealed within the apparently atrophic left adrenal gland. Soon after the second surgery, her blood pressure normalized without requiring any anti-hypertensive medication.


Subject(s)
Adrenalectomy , Adrenocortical Adenoma , Aldosterone/blood , Hydrocortisone/blood , Hypertension/etiology , Adrenal Cortex/diagnostic imaging , Adrenal Cortex/pathology , Adrenal Cortex Neoplasms/blood , Adrenal Cortex Neoplasms/complications , Adrenal Cortex Neoplasms/diagnostic imaging , Adrenal Cortex Neoplasms/surgery , Adrenocortical Adenoma/blood , Adrenocortical Adenoma/complications , Adrenocortical Adenoma/diagnostic imaging , Adrenocortical Adenoma/surgery , Cushing Syndrome/blood , Cushing Syndrome/diagnostic imaging , Cushing Syndrome/etiology , Cushing Syndrome/therapy , Female , Humans , Hyperaldosteronism/blood , Hyperaldosteronism/diagnostic imaging , Hyperaldosteronism/etiology , Hyperaldosteronism/therapy , Hypertension/blood , Hypertension/physiopathology , Hypertension/therapy , Middle Aged , Tomography, X-Ray Computed , Treatment Outcome
4.
Nephron ; 85(2): 175-7, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10867524

ABSTRACT

A 50-year-old woman developed renin-dependent hypertension immediately after accidental unilateral ureteral ligation during hysterectomy, and the hypertension lasted for 5 months. Surgical release of the obstruction was carried out 157 days after the ligation. Then, her blood pressure was normalized. However, the obstructed kidney showed intensive tubulointerstitial fibrosis and functional recovery was not obtained. This case suggests that the renin-angiotensin system may be upregulated in human kidney during unilateral ureteral obstruction for a long duration.


Subject(s)
Hypertension/etiology , Renin/physiology , Ureteral Obstruction/complications , Atrophy , Chronic Disease , Female , Fibrosis , Humans , Hypertension/physiopathology , Hysterectomy/adverse effects , Kidney/pathology , Kidney/physiopathology , Ligation/adverse effects , Middle Aged , Ureteral Obstruction/diagnosis , Ureteral Obstruction/physiopathology
5.
Int J Urol ; 7(6): 218-23, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10843453

ABSTRACT

BACKGROUND: Simultaneous determinations of human chorionic gonadotropin hormone (hCG) and hCG-beta frequently produce discrepancies, that is when hCG or hCG-beta is normal, the other is elevated. Accordingly, we examined the significance of simultaneous determination of serum hCG and hCG-beta in testicular tumors. METHODS: Simultaneous determination of hCG and hCG-beta was performed in 54 patients with testicular seminoma and 74 with non-seminomatous testicular tumors. RESULTS: For detection of seminoma patients, hCG-beta was more effective than hCG because hCG-beta was positive in 83% (45/54) of the patients and hCG was positive in 50% (27/54). In non-seminomatous testicular tumor cases, hCG-beta was positive in 74% (55/74) and hCG was positive in 82% (61/74). The cases of hCG<1.0 mIU/mL and HCG-beta>0.1 ng/mL were significantly more frequently seen in patients with seminoma than in those with non-seminomatous testicular tumor (P < 0.001). Fourteen patients had recurrent tumor. At recurrence, only hCG was elevated in nine cases, only hCG-beta was elevated in two cases and both in one case. For diagnosis of falsely positive hCG, testosterone administration was effective because after testosterone administration, serum hCG levels became undetectable (< 1.0 mIU/mL) within one week in three examined cases. CONCLUSION: Human chorionic gonadotropin-beta was a better marker of seminoma than hCG. For earlier detection of recurrence, both markers should be examined. For diagnosis of falsely positive hCG, testosterone administration was effective.


Subject(s)
Chorionic Gonadotropin, beta Subunit, Human/blood , Seminoma/blood , Seminoma/diagnosis , Testicular Neoplasms/blood , Testicular Neoplasms/diagnosis , Adult , Biomarkers , Chorionic Gonadotropin, beta Subunit, Human/analysis , Chorionic Gonadotropin, beta Subunit, Human/immunology , Cross Reactions , False Positive Reactions , Humans , Male , Neoplasm Recurrence, Local
6.
Nihon Hinyokika Gakkai Zasshi ; 91(2): 69-74, 2000 Feb.
Article in Japanese | MEDLINE | ID: mdl-10723179

ABSTRACT

BACKGROUND: It has been demonstrated that leukocyte infiltration, mainly of macrophages and lymphocytes, into obstructed kidneys (OBK) of rats during unilateral ureteral obstruction (UUO). Chemokines (C-C subfamily) may be involved in this mechanisms. Thus, we accessed the gene expression of chemokines in renal cortex of rats with UUO. MATERIALS AND METHODS: Female SD rats were sacrificed at various time points after UUO. mRNA expression of MCP-1, RANTES and MIP-1 alpha was determined by semi-quantitative RT-PCR. RESULTS: Control kidneys (CNK) showed a weak mRNA expression of MCP-1, RANTES and MIP-1 alpha. OBKs showed an increase in MCP-1 at 2 hours of UUO and a significant increase at 4 hours of UUO as compared with CNKs or contralateral unobstructed kidneys (CLK). The mRNA levels of RANTES and MIP-1 alpha were not increased until 72 hours of UUO in CLKs or OBKs. There were slight, but significant, differences of RANTES and MIP-1 alpha expression between OBKs and CNKs at 120 hours of UUO. CONCLUSIONS: We suggest that the early increase in MCP-1 contributes to the leukocyte infiltration and that RANTES and MIP-1 alpha plays a partial role in a late increases.


Subject(s)
Chemokines/metabolism , Kidney/metabolism , Ureteral Obstruction/metabolism , Animals , Cell Movement , Chemokines/genetics , Chronic Disease , Disease Models, Animal , Female , Leukocytes/pathology , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Ureteral Obstruction/pathology
7.
Int J Urol ; 7(11): 415-20, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11144652

ABSTRACT

BACKGROUND: Unilateral ureteral obstruction (UUO) of rats is a well-established model for studying obstructive nephropathy. Meanwhile, pathophysiology of pediatric obstructive nephropathy is not well understood. In this report, we studied monocyte/macrophage infiltration and expression of intercellular adhesion molecule 1 (ICAM-1) and macrophage antigen 1 (Mac-1) in weanling rats with UUO. METHODS: Three-week-old male Sprague-Dawley rats underwent left unilateral ureteral ligation. Both obstructed kidneys (OBK) and contralateral kidneys (CLK) were harvested at 3, 6, 12, 24, 72 and 120 h after surgery. Monocyte/macrophage infiltration and expression of ICAM-1 and Mac-1 were evaluated immunohistochemically, and results were compared with those of sham-operated control rats (SOK). RESULTS: Monocyte/macrophage infiltration was observed in the interstitium and perivascular region in the cortex of OBK within 6 h. The CLK and SOK showed slight monocyte/macrophage infiltration. Expression of ICAM-1 was markedly observed in the periarterial and peritubular interstitium and in renal cortical peritubular capillaries 12 h after obstruction. In CLK and SOK, ICAM-1 was slightly expressed in the endothelium of microvessels and parietal linings of Bowman's capsule. Expression of Mac-1 was detected mainly in cells infiltrating the perivascular interstitium in OBK. In CLK and SOK, few Mac-1-positive cells were observed. CONCLUSIONS: Adhesion molecules, ICAM-1 and Mac-1, are expected to recruit monocyte/macrophage infiltration into OBK of weanling rats with UUO.


Subject(s)
Cell Adhesion Molecules/physiology , Intercellular Adhesion Molecule-1/immunology , Macrophage-1 Antigen/immunology , Macrophages/immunology , Monocytes/immunology , Ureteral Obstruction/immunology , Animals , Animals, Newborn , Male , Rats , Rats, Sprague-Dawley
8.
Tohoku J Exp Med ; 192(4): 249-58, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11286315

ABSTRACT

Treatment by internal iliac arterial infusion chemotherapy (IA) combined with pelvic irradiation has proved to be effective for locally invasive bladder. Eight male patients, median age of 78 years (range 73-81) were enrolled. Pretreatment CT and whole layer core biopsy revealed T3a or T3b. Pelvic CT or fine needle aspiration biopsy following bipedal lymphography revealed N0 in 4 cases, N2 in 2 and N3 in 2, respectively. Three to 7 cycles of cisplatin (CDDP) 30-50 mg/m2, methotrexate 20 mg/m2 and tetrahydropymnyl-adriamycin 20 mg/m2 every 3 week was administered combined with 40-50 Gy. of whole pelvis irradiation. In 4 renal function impaired patients, 100 mg/m2 of carboplatin was administered instead of CDDP. All patients obtained complete response and the bladders were preserved. Observation periods were from 9 to 75 months (median 37 months). One N2 patient died with metastatic disease and two died without carcinoma. Two patients developed invasive bladder cancer on the side opposite to the primary tumors. Both were successfully treated by IA and irradiation. Bladders of all except one patient functioned for a long period. Side effects of IA and irradiation were not significant. IA combined with pelvic irradiation is effective and safe for elderly patients with bladder carcinoma.


Subject(s)
Antineoplastic Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cisplatin/therapeutic use , Doxorubicin/therapeutic use , Health Services for the Aged/statistics & numerical data , Methotrexate/therapeutic use , Urinary Bladder Neoplasms/drug therapy , Urinary Bladder/physiology , Aged , Aged, 80 and over , Antineoplastic Agents/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Cisplatin/administration & dosage , Doxorubicin/administration & dosage , Humans , Infusions, Intra-Arterial , Lymphatic Metastasis , Male , Methotrexate/administration & dosage , Tomography, X-Ray Computed , Urinary Bladder/diagnostic imaging , Urinary Bladder Neoplasms/radiotherapy
9.
Kidney Int ; 56(6): 2137-46, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10594789

ABSTRACT

UNLABELLED: Increased expression of TGF-beta1 but not of its receptors contributes to human obstructive nephropathy. BACKGROUND: Previous studies have revealed an increased expression of transforming growth factor-beta1 (TGF-beta1) and deposition of extracellular matrix in the kidney of animals with ureteral obstruction. However, these relationships have not been elucidated in the hydronephrotic kidney of humans. METHODS: We analyzed the tissue expression of extracellular matrix proteins, TGF-beta1, and its receptors in the human kidney with ureteral obstruction by immunohistochemistry and reverse transcription-polymerase chain reaction (RT-PCR). Obstructed kidneys (OBKs) were obtained from patients with ureteral tumors. A kidney specimen from patients with a renal tumor was used as control (CNKs). RESULTS: The interstitial volume was significantly increased in OBKs in comparison with CNKs. OBKs showed increased deposition of collagen types I and IV and fibronectin in the renal interstitium. RT-PCR revealed overexpression of collagen alpha1(IV) mRNA and fibronectin mRNA in OBKs. OBKs showed a significantly increased mRNA expression of TGF-beta1 in comparison with CNKs. The immunoreactivity for TGF-beta1 increased markedly in the interstitium of OBKs. There was a significant correlation between the TGF-beta1 mRNA level and the interstitial volume. However, there was no significant difference between OBKs and CNKs in the relative mRNA level nor in immunoreactivity for TGF-beta receptors. CONCLUSIONS: These data suggest that TGF-beta1 may contribute to the interstitial fibrosis found in the human kidney with ureteral obstruction, mainly because of an increase in the expression of this cytokine without significant changes to its receptors.


Subject(s)
Activin Receptors, Type I , Protein Serine-Threonine Kinases/genetics , Receptors, Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/genetics , Ureteral Obstruction/physiopathology , Adult , Aged , Antisense Elements (Genetics) , Collagen/genetics , Extracellular Matrix Proteins/genetics , Female , Fibronectins/genetics , Fibrosis , Gene Expression , Humans , Hydronephrosis/genetics , Hydronephrosis/pathology , Hydronephrosis/physiopathology , Kidney Cortex/chemistry , Kidney Cortex/pathology , Kidney Cortex/physiopathology , Male , Middle Aged , Protein Serine-Threonine Kinases/analysis , RNA, Messenger/analysis , Receptor, Transforming Growth Factor-beta Type I , Receptor, Transforming Growth Factor-beta Type II , Receptors, Transforming Growth Factor beta/analysis , Transforming Growth Factor beta/analysis , Ureteral Obstruction/genetics , Ureteral Obstruction/pathology
10.
Nihon Hinyokika Gakkai Zasshi ; 90(5): 579-85, 1999 May.
Article in Japanese | MEDLINE | ID: mdl-10386058

ABSTRACT

OBJECT: The objectives of this study are to examine how many cancer patients we can detect among the outpatients whose PSA values are above 4.0 ng/ml, and to compare the usefulness of transperineal six sextant biopsy (ss-biopsy) with that of transrectal one. METHODS: All the male outpatients (above 50 years old) were inspected Tandem-R PSA levels and digital rectal examination (DRE). Among them, 129 patients showed more than 4.0 ng/ml of PSA values and/or positive finding of DRE, and underwent subsequent transperineal ss-biopsy. RESULTS: Cancers were detected in 52 patients (40.3%) without major complications. Among 64 gray zone (PSA 4.1-10.0 ng/ml) patients, 17 (26.6%) were found to be cancer by ss-biopsy, meanwhile only 2 cancer patients (8.9%) were detected from 23 gray zone ones by traditional directed biopsy. Application of PSA density could not be found practicable to eliminate unnecessary biopsies in the gray zone group. CONCLUSION: Prostate cancer could be found nearly a fourth in the gray zone group of the outpatients. To enhance the detection rate, obtaining at least 6 core samples are recommended from either perineal or rectal root.


Subject(s)
Biomarkers, Tumor/blood , Biopsy/methods , Mass Screening , Prostate-Specific Antigen/blood , Prostatic Neoplasms/diagnosis , Aged , Humans , Male , Middle Aged
11.
Int J Urol ; 6(5): 245-50, 1999 May.
Article in English | MEDLINE | ID: mdl-10375187

ABSTRACT

BACKGROUND: Cisplatin is widely used in cancer treatment. The major disadvantage of this antitumor agent is its nephrotoxicity. The mechanism of cisplatin-induced nephrotoxicity has not been clarified. Recent evidence suggests protein kinase C (PKC)-related signal transduction pathways may modulate cisplatin-induced cytotoxicity. METHODS: The effect of cisplatin administration on PKC expression in the kidney and the effect of a PKC inhibitor on cisplatin-induced renal impairment were investigated in rats. RESULTS: A single intraperitoneal injection of 8 mg/kg cisplatin induced remarkable damage in the proximal tubules located in the outer medulla, which was associated with impaired renal function, within 48 h. An immunoblotting study revealed marked expression of alpha-PKC in membrane fractions of medullary tubules prepared from cisplatin-treated rats. In addition, pretreatment with the PKC inhibitor (H-7) protected kidneys from cisplatin-induced damage. CONCLUSIONS: These findings suggest that the nephrotoxic effects of cisplatin may, in part, be related to PKC activation in the renal tubules.


Subject(s)
Antineoplastic Agents/toxicity , Cisplatin/toxicity , Kidney Diseases/enzymology , Kidney Tubules, Proximal/enzymology , Protein Kinase C/biosynthesis , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/pharmacology , Animals , Antineoplastic Agents/administration & dosage , Cisplatin/administration & dosage , Disease Models, Animal , Enzyme Inhibitors/pharmacology , Immunoblotting , Immunoenzyme Techniques , Injections, Intraperitoneal , Kidney Diseases/chemically induced , Kidney Diseases/pathology , Kidney Function Tests , Kidney Tubules, Proximal/drug effects , Kidney Tubules, Proximal/pathology , Male , Protein Kinase C/antagonists & inhibitors , Rats , Signal Transduction/drug effects
12.
Nihon Hinyokika Gakkai Zasshi ; 88(1): 46-52, 1997 Jan.
Article in Japanese | MEDLINE | ID: mdl-9038052

ABSTRACT

BACKGROUND: Pulmonary resection for metastatic renal cell carcinoma were studied to assess the indication of surgical management. METHODS: Between January, 1981 and December 1994, 17 consecutive patients (14 men and 3 women) underwent complete pulmonary resection for metastatic renal carcinoma. Median age was 61 years (range, 45 to 73 years). Eleven were appeared lung metastasis after resection of primary tumor. Median time between nephrectomy and pulmonary resection was 32 months (range, 0 to 127 months). RESULTS: There were no operative deaths. One patient had solitary metastasis, 4 had two, 2 had three, 2 had four, one had seven, one had eight and 6 had more than twenty-two. Segmental resection was performed in 12 patients, lobectomy in 2, lobectomy and segmentectomy in 3 and segmentectomy for total lobes in 3. Four patients had another site operation of renal metastasis, brain tumor resection, chest wall and ribs resection, contra-lateral adrenalectomy and contralateral partial nephrectomy. Median follow-up was 44 months (range, 10 to 129 months). The cause specific survival rate and disease free survival after pulmonary resection was 55 and 48 percent at 5 years and 27 and 14 percent at 10 years, respectively. CONCLUSION: Pulmonary resection for metastatic renal cell carcinoma was considered effective in some selected slow-growing cases. Multiple and both lungs metastases is not contraindication and the patients under 10 metastatic focuses had good prognosis.


Subject(s)
Carcinoma, Renal Cell/secondary , Carcinoma, Renal Cell/surgery , Kidney Neoplasms/pathology , Lung Neoplasms/secondary , Lung Neoplasms/surgery , Pneumonectomy , Aged , Carcinoma, Renal Cell/mortality , Female , Humans , Lung Neoplasms/mortality , Male , Middle Aged , Survival Rate
13.
Kidney Int Suppl ; 57: S84-92, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8941927

ABSTRACT

Long-term unilateral ureteral obstruction (UUO) initiates a series of renal events leading to proliferation of interstitial fibroblasts and proliferation/repair of tubular cells. This is evidenced by significant increases in proliferating cell nuclear antigen (PCNA) positive nuclei during UUO. Several pathologic settings requiring DNA replication and/or DNA repair are dependent upon the expression of p53 and at least one of two p53-dependent proteins, termed p21 (also called WAF1) and GADD45. We therefore sought to determine if p53, p21 (WAF1) or GADD45 mRNA levels were changed in obstruction. There was a progressive increase in the amount of p53 mRNA and p21 (WAF1) mRNA at 1, 3, 5 and 8 days of continuous UUO. The amount of GADD45 mRNA was found not to change. Treatment of the experimental animals with an ACE inhibitor on day 4 through day 8 of UUO significantly blunted the increase in p53 and p21 (WAF1) expression. ACE inhibitor treatment also significantly decreased the number of PCNA-positive renal cell nuclei during UUO. These results suggest that during ureteral obstruction the p53 and p21 (WAF1) genes are activated. ACE inhibitor treatment reduces p53 and p21 (WAF1) expression. This reduction is at least in part due to an inhibition of interstitial cell proliferation.


Subject(s)
Cyclins/metabolism , Proteins/metabolism , Tumor Suppressor Protein p53/metabolism , Ureteral Obstruction/metabolism , Animals , Base Sequence , Biomarkers , Cyclin-Dependent Kinase Inhibitor p21 , Cyclins/genetics , Female , Intracellular Signaling Peptides and Proteins , Kidney Cortex/metabolism , Molecular Sequence Data , Proliferating Cell Nuclear Antigen/metabolism , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , GADD45 Proteins
14.
J Am Soc Nephrol ; 7(10): 2202-12, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8915981

ABSTRACT

Angiotensin-converting enzyme (ACE) inhibitors have been shown to minimize fibrosis of the kidney tubulointerstitium in several diseases. In addition to lowering angiotensin II levels, ACE inhibitors can increase kinin levels and subsequently increase nitric oxide formation. To determine whether nitric oxide generation is a component of the beneficial effect of ACE inhibitors on renal fibrosis, enalapril, enalapril plus NG-nitro-L-arginine methyl ester (L-NAME) or L-arginine was administered to rats that had undergone unilateral ureteral obstruction (UUO). Ureteral obstruction caused significant increases in interstitial volume, monocyte macrophage infiltration, interstitial collagen IV and alpha-smooth muscle actin expression, transforming growth factor-beta 1 mRNA, collagen IV mRNA, and tissue inhibitor of metalloproteinase-1 mRNA. Enalapril treatment significantly blunted the increase in all parameters during UUO. Cotreatment of the animals with enalapril and L-NAME reversed the beneficial effect of enalapril in the obstructed kidney for all parameters. Treatment of animals with UUO with L-arginine significantly blunted the increase in all parameters except for transforming growth factor-beta 1 mRNA expression. In the enalapril- plus-L-NAME-treated animals, there were modest but significant increases in monocyte/macrophage infiltration of the interstitium and glomerulus, and collagen IV and alpha-smooth muscle actin expression in the interstitium of the contralateral unobstructed kidney. The urine nitrite concentration was significantly increased by either enalapril or L-arginine treatment, whereas L-NAME significantly reduced urine nitrite concentration. These results suggest that treatment modalities that increase nitric oxide formation have a beneficial effect on the progression of cellular and molecular parameters of tubulointerstitial fibrosis caused by obstruction of the ureter.


Subject(s)
Kidney Diseases/metabolism , Kidney Diseases/pathology , Kidney Tubules/pathology , Nitric Oxide/biosynthesis , Ureteral Obstruction/complications , Actins/metabolism , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Animals , Arginine/pharmacology , Collagen/metabolism , Enalapril/pharmacology , Enzyme Inhibitors/pharmacology , Female , Fibrosis , Kidney/metabolism , Kidney Diseases/etiology , Kidney Tubules/drug effects , Muscle, Smooth/metabolism , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide/antagonists & inhibitors , Rats , Rats, Sprague-Dawley
15.
Int J Urol ; 3(5): 386-91, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8886917

ABSTRACT

BACKGROUND: Urinary tract obstruction has a marked effect on renal function. Activation of phospholipases which results in incremental production of vasoactive eicosanoids may contribute to the hemodynamic changes characteristic of an obstructed kidney. G proteins play an important role in transmembrane signal transduction, which control phospholipase activities and eicosanoid production. The present study was designed to determine the presence of G proteins in obstructed kidneys in rats, and to characterize the differences between unilateral ureteral obstruction (UUO) and bilateral ureteral obstruction (BUO). METHODS: Several G-protein alpha subunits (G alpha s, G alpha i1,2, and G alpha i3) and the beta subunit (G beta) were determined by immunoblotting and immunocytochemical techniques using specific antibodies against these G proteins. RESULTS: Immunoblots demonstrated a decreased G alpha i3 content in the outer medullary tubules and a significantly lower G beta level in the glomeruli of UUO. In BUO, there was an increased level of G beta in the cortical tubules, and the G alpha s level was markedly reduced in the inner medullary tubules. Immunocytochemical studies revealed that these G proteins were predominantly localized in the brush border side of the cortical tubules. However, we could not demonstrate staining differences between UUO and BUO. CONCLUSIONS: These results indicate that a modulation of G-protein-coupled transmembrane signal transduction may contribute to the renal functional changes in an obstructed kidney. A different level of expression of G-protein subunits between UUO and BUO may be a factor in the differences of hemodynamics and renal tubular damage between UUO and BUO.


Subject(s)
GTP-Binding Proteins/metabolism , Kidney Glomerulus/metabolism , Kidney Tubules/metabolism , Renal Insufficiency/metabolism , Ureteral Obstruction/metabolism , Animals , Female , Immunoblotting , Immunohistochemistry , Kidney Glomerulus/pathology , Kidney Tubules/pathology , Rats , Rats, Sprague-Dawley , Renal Insufficiency/etiology , Renal Insufficiency/pathology , Ureteral Obstruction/complications , Ureteral Obstruction/pathology
16.
Kidney Int Suppl ; 54: S83-7, 1996 May.
Article in English | MEDLINE | ID: mdl-8731201

ABSTRACT

Tubulointerstitial fibrosis in unilateral ureteral obstruction (UUO) is driven by increased levels of angiotensin II (AII). In this study we administered the angiotensin converting enzyme (ACE) inhibitor enalapril to rats with UUO after tubulointerstitial fibrosis was established. Treatment with the ACE inhibitor halted the progression of fibrosis and to a significant extent reversed some aspects of tubulointerstitial fibrosis. It is suggested that enalapril administration may be an effective means of preventing the progression of tubulointerstitial fibrosis.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/pharmacology , Extracellular Matrix/metabolism , Gene Expression/drug effects , Genes, p53/drug effects , Kidney Diseases/pathology , Oncogene Protein p21(ras)/biosynthesis , Animals , Collagen/metabolism , Extracellular Matrix/drug effects , Extracellular Matrix/ultrastructure , Fibrosis/metabolism , Fibrosis/pathology , Glycoproteins/biosynthesis , Immunohistochemistry , Kidney Diseases/metabolism , Male , Nephritis, Interstitial/pathology , Oncogene Protein p21(ras)/genetics , RNA/biosynthesis , RNA/isolation & purification , Rats , Rats, Sprague-Dawley , Tissue Inhibitor of Metalloproteinases , Transforming Growth Factor beta/biosynthesis
17.
Kidney Int ; 49(4): 1110-9, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8691732

ABSTRACT

Tubulointerstitial fibrosis in unilateral ureteral obstruction (UUO) is driven by increased levels of angiotensin II (Ang II). In this study, we examined the time course of the fibrotic process in rats with UUO and explored the effect of delayed administration of an angiotensin converting enzyme (ACE) inhibitor, enalapril, on the tubulo-interstitial fibrosis of obstructive uropathy. Rats were sacrificed at 3, 5, 8, or 10 days after UUO was initiated. Some rats did not receive treatment, whereas others were treated with enalapril from day 4 to day 8 or from day 6 to day 10 after the onset of UUO. The levels of mRNA for transforming growth factor beta 1 (TGF-beta 1), collagen type IV (collagen IV), and tissue inhibitor of metalloproteinase (TIMP-1) were measured at each time point by reverse transcription-polymerase chain reaction (RT-PCR). The relative volume of the tubulointerstitium (Vv) was measured by a point-counting method. Monocyte/macrophage infiltration and collagen IV protein deposition were examined histologically using specific antibodies. There were significant increases in TGF-beta 1, TIMP-1, and collagen IV mRNAs in the obstructed kidney. Treatment with enalapril on day 4 through day 8 or on day 6 through day 10 significantly reduced the elevated mRNA levels of these compounds in the obstructed kidney. Histological studies showed augmented Vv, monocyte/macrophage infiltration, interstitial alpha-smooth muscle actin expression, and collagen IV protein deposition on days 3, 5, 8, or 10 of UUO; enalapril treatment from day 4 to 8 or from day 6 to 10 halted and to an extent reversed these increases. These data suggest that enalapril administration after several days of UUO is an effective means of preventing the progression of tubulointerstitial fibrosis of obstructive uropathy.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/pharmacology , Enalapril/pharmacology , Nephritis, Interstitial/drug therapy , Ureteral Obstruction/drug therapy , Actins/analysis , Animals , Base Sequence , Collagen/analysis , Collagen/genetics , Female , Fibroblasts/pathology , Fibrosis , Glycoproteins/genetics , Immunohistochemistry , Macrophages/pathology , Molecular Sequence Data , Muscle, Smooth/chemistry , Nephritis, Interstitial/genetics , Nephritis, Interstitial/pathology , Polymerase Chain Reaction , Protease Inhibitors/metabolism , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Time Factors , Tissue Inhibitor of Metalloproteinases , Transforming Growth Factor beta/genetics , Ureteral Obstruction/genetics , Ureteral Obstruction/pathology
18.
Am J Kidney Dis ; 26(1): 141-6, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7611245

ABSTRACT

Chronic unilateral ureteral obstruction results in interstitial fibrosis of the affected kidney. Both an angiotensin-converting enzyme inhibitor, enalapril, and an angiotensin II receptor antagonist, SC-51316, ameliorate the increased production of extracellular matrix protein in the tubulointerstitium of the obstructed kidney. Blockade of angiotensin II synthesis or inability of angiotensin II to bind to its receptor lessened the increased levels of mRNA for transforming growth factor-beta and collagen IV found in the obstructed kidney of untreated rats. A monocyte/macrophage infiltration was present in the obstructed kidney of untreated rats or rats treated with the angiotensin II receptor antagonists. In contrast, this infiltrate was almost completely absent in the obstructed kidney of rats treated with enalapril. The reason for this different effect of enalapril compared with the angiotensin II receptor antagonist on the macrophage infiltrate seen in obstructive nephropathy has not been elucidated. We conclude that both an angiotensin-converting enzyme inhibitor (enalapril) and a receptor antagonist of angiotensin II ameliorate the tubulointerstitial fibrosis that follows complete unilateral ureteral obstruction in the rat. We suggest that an increased level of angiotensin II has a major role in the development of tubulointerstitial fibrosis following ureteral obstruction.


Subject(s)
Angiotensin II/physiology , Kidney Diseases/pathology , Kidney Tubules/pathology , Kidney/pathology , Ureteral Obstruction/complications , Angiotensin Receptor Antagonists , Animals , Collagen/metabolism , Enalapril/pharmacology , Extracellular Matrix Proteins/biosynthesis , Fibrosis , Kidney/drug effects , Kidney/metabolism , Kidney Diseases/etiology , Kidney Diseases/metabolism , Kidney Tubules/drug effects , Kidney Tubules/metabolism , Macrophages/drug effects , Macrophages/pathology , Monocytes/drug effects , Monocytes/pathology , RNA, Messenger/metabolism , Rats , Tetrazoles/pharmacology , Transforming Growth Factor beta/genetics , Triazoles/pharmacology
19.
Kidney Int ; 47(5): 1458-61, 1995 May.
Article in English | MEDLINE | ID: mdl-7543626

ABSTRACT

Using homology-based polymerase chain reaction (PCR) amplification, we demonstrate the presence of arginine decarboxylase mRNA in tissues involved in arginine metabolism (brain, kidney, gut, adrenal gland, and liver of the rat) but not in organs (lung, heart, and spleen) in which arginine metabolism is low or absent. The polymerase chain reaction product from the kidney had a nucleotide sequence 61% identical to that of the E. coli biosynthetic arginine decarboxylase. On a whole tissue basis, kidney homogenates were three times more active than brain homogenates at decarboxylating [1-14C]arginine. Subcellular fractionation localized the arginine decarboxylase activity of the kidney to the mitochondria fraction. Agmatine, one of the products of arginine decarboxylation, was found to inhibit nitric oxide formation by post-mitochondrial supernatants of the brain or kidney. We propose that arginine is metabolized to two structurally different signaling molecules, nitric oxide and agmatine. Furthermore, agmatine can influence the nitric oxide synthase pathway.


Subject(s)
Carboxy-Lyases/analysis , Cloning, Molecular , Kidney Cortex/enzymology , Agmatine/pharmacology , Amino Acid Oxidoreductases/antagonists & inhibitors , Animals , Arginine/metabolism , Base Sequence , Carboxy-Lyases/genetics , Female , Molecular Sequence Data , Nitric Oxide Synthase , RNA, Messenger/analysis , RNA, Messenger/genetics , Rats , Rats, Sprague-Dawley , Sequence Homology, Nucleic Acid
20.
Kidney Int ; 47(5): 1285-94, 1995 May.
Article in English | MEDLINE | ID: mdl-7637258

ABSTRACT

Unilateral ureteral obstruction (UUO) results in tubulointerstitial fibrosis of the obstructed kidney (OBK). In this study we report that a specific angiotensin II (Ang II) receptor antagonists, SC-51316, ameliorates the expansion of the renal cortical interstitium in the OBK of the rat at five days of UUO. This is similar to the effect of an angiotensin converting enzyme (ACE) inhibitor, enalapril. SC-51316 (20 mg/liter in the drinking water) or enalapril (200 mg/liter in the drinking water) was administered beginning 24 hours before UUO and continued through five days after UUO. The relative volume of the tubulointerstitium (Vv) was measured by a point-counting method, and monocyte/macrophage infiltration, alpha smooth muscle actin (alpha SMA), proliferating cell nuclear antigen (PCNA), and collagen type IV (collagen IV) protein deposition were examined histologically using specific antibodies. We also examined the mRNA levels of transforming growth factor beta 1 (TGF-beta 1) and collagen IV by reverse transcription polymerase chain reaction. In untreated rats with UUO, Vv was remarkably expanded; collagen IV and alpha SMA protein deposition in the interstitium and PCNA labeling of nuclei were increased. These changes were significantly ameliorated by administration of an ACE inhibitor or an Ang II receptor antagonist. A monocyte/macrophage infiltration was evident in the OBK of untreated or Ang II receptor antagonist treated rats but was greatly reduced in the OBK of rats given enalapril. Increased expression of TGF-beta 1 mRNA and collagen IV mRNA was blunted (40 to 75%) by the administration of Ang II receptor antagonist or enalapril. The Ang II receptor antagonist or the ACE inhibitor did not affect the contralateral kidney of rats with UUO or the control kidney of normal rats. This study indicates that the renin-angiotensin system has a major role in the pathogenesis of the tubulointerstitial fibrosis of obstructive nephropathy. The tubulointerstitial fibrosis of obstructive nephropathy is most likely mediated by an increased level of Ang II in renal tissue.


Subject(s)
Angiotensin Receptor Antagonists , Enalapril/therapeutic use , Nephritis, Interstitial/drug therapy , Tetrazoles/therapeutic use , Triazoles/therapeutic use , Ureteral Obstruction/complications , Actins/metabolism , Animals , Blood Pressure/drug effects , Collagen/metabolism , Disease Models, Animal , Female , Immunohistochemistry , Monocytes/physiology , Nephritis, Interstitial/etiology , Nephritis, Interstitial/metabolism , Nephritis, Interstitial/pathology , Proliferating Cell Nuclear Antigen/metabolism , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Renin/blood , Renin/drug effects , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...